Biogena Group Invest AG (WBO:BIO) FFO


WBO:BIO Biogena Group Invest AG WBO:BIO
66 GF Score
Price €4.18
GF Value €3.46
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is Biogena Group Invest AG FFO?

FFO (Funds from operations) only applies to REITs.

WBO:BIO
66GF Score
Biogena Group Invest AG WBO:BIO
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Biogena Group Invest AG (WBO:BIO) Overvalued in 2026?

Based on GuruFocus' analysis, Biogena Group Invest AG stock appears to be overvalued. The current stock price of €4.18 is trading 20.8% above its estimated GF Value™ of €3.46. GuruFocus considers Biogena Group Invest AG to be Modestly Overvalued.

Key valuation signals for WBO:BIO:

  • FFO:
  • GF Value™: €3.46 vs. price of €4.18 (20.8% above fair value)
  • GF Score™: 66/100 with 6 warning signs

No single metric tells the full story. See the WBO:BIO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Biogena Group Invest AG Business Description

Address Strubergasse 24, Salzburg, AUT, 5020
Biogena Group Invest AG is a holding company. It is engaged in the development and distribution of products and services in the field of health and nutrition. In particular, the focus is on iron, mineral and osteoporosis product innovations and new integrated solutions in the area of workplace health promotion. Its products include vitamin, mineral, enzymes, medicinal mushrooms, among others.
66GF Score

Get the complete analysis for WBO:BIO

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.18
Price
€3.46
GF Value